explore | Grilled Cheese

NeuroSense Therapeutics to Showcase Innovations at the 5th Annual ROTH Healthcare Opportunities Conference #United_States #New_York #ALS #NeuroSense #PrimeC

🧠 Neuro Talk Evening Nr. 20

Join us on October 8, 2026, at 6:00 PM (CEST) for insights into cellular mechanisms of motor neuron diseases!

🔗 For more details, visit our website and sign-up via our bio!

#nte #neuroscience #studentnetwork #neurons #motorneurons #cells #molecular #ALS #biology

Explore the details: https://bit.ly/4hAsKMH

A progressive decline in lung function is unavoidable in ALS, but there are steps that patients can take to improve breathing issues.

#ALS #ALSNewsToday #Bionews #ALSCommunity

SOLA Details ¥6 Billion AMED-Backed Plan for ALS Gene Therapy SOLA Biosciences outlined how an approximately ¥6 billion Japanese government grant is supporting development of its...

https://www.narrowit.com/news/sola-biosciences-amed-grant-sol257-als-2026-09-28
#SolaBiosciences #ALS #SOL257 #AMED

Coya Therapeutics hits its 100th ALS trial enrollment and publishes new preclinical data, both pointing to the same immune-cell mechanism.

Link as first comment.

#longevity #geroscience #ALS #immunecells #preclinical

SOLA Biosciences Japan Receives AMED Grant for ALS Gene Therapy Development #Japan #Tokyo #ALS #SOLA_Biosciences #SOL-257

SOLA Biosciences Japan Secures AMED Grant for Gene Therapy Advancements #Japan #Tokyo #ALS #AMED #SOLA_Biosciences

SOLA Biosciences JapanがAMEDの支援を受けALS治療に挑む #ALS #SOLA_Biosciences #TDP-43

合同会社SOLA Biosciences JapanがAMEDからの支援を受け、遺伝子治療SOL-257を開発中。この治療法はALSの原因となるTDP-43に着目し、その機能回復を目指します。

進化するALS治療：SOLA Biosciences Japanが大きな一歩を踏み出す #東京都 #ALS #遺伝子治療 #SOLA_Biosciences

合同会社SOLA Biosciences JapanがAMEDの事業に採択され、ALS治療に向けた遺伝子治療SOL-257の開発に挑む。新たなアプローチの詳細を追う。

Really pleased for David and Chloe to see this published. Was a great collaboration

#ALS #MND #SOD1 #metabolicdysfunction

@uclqsion.bsky.social

Families living with ALS learn to manage fear, love, and responsibility all at once. It takes a community’s support, along with immense love and strength.

#ALS

N-of-1!

An investigational study of a novel individualised antisense oligonucleotide drug for CHCHD10-related #ALS shows early signs of efficacy in a 12-month N-of-1 study; Well tolerated, normalised plasma NfL levels & modest clinical improvements
www.cell.com/med/abstract...

NeuroSense's Strategies and Financial Results for the First Half of 2026 #United_States #Cambridge #ALS #NeuroSense #PrimeC

Families adjusting to ALS build new routines constantly. It’s not easy work, and it’s okay if it feels messy or imperfect.

#ALS

Discover more: https://bit.ly/3TT7da2

Low muscle mass in the arms and legs and sarcopenia were linked to poorer survival in people with ALS in a small prospective study.

#ALS #ALSNewsToday #Bionews #ALSCommunity

Many years ago my young brother died of #ALS at 34 years old. He played football...on ASTRO TURF. Coincidence, I'm wondering... 🤔

A targeted treatment for a rare genetic form of ALS has met its main goal in a Phase 3 trial.